"L-Selectin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules.
| Descriptor ID |
D019041
|
| MeSH Number(s) |
D12.776.395.550.200.625.903 D12.776.395.550.200.700.510 D12.776.503.843.510 D12.776.543.550.200.625.903 D12.776.543.550.200.700.510 D12.776.543.750.705.877.903 D23.050.301.350.625.903 D23.050.301.350.700.510
|
| Concept/Terms |
L-Selectin- L-Selectin
- Mel-14 Antigen
- Antigen, Mel-14
- Mel 14 Antigen
- L Selectin
- Selectin, L
- LAM-1
- CD62L Antigens
- Leu-8 Antigen
- Antigen, Leu-8
- Leu 8 Antigen
- TQ1 Antigen
- Antigen, TQ1
- CD62L Antigen
- Antigen, CD62L
- Antigens, CD62L
- Leukocyte Adhesion Molecule, LAM-1
- Leukocyte Adhesion Molecule, LAM 1
- LECAM-1
|
Below are MeSH descriptors whose meaning is more general than "L-Selectin".
Below are MeSH descriptors whose meaning is more specific than "L-Selectin".
This graph shows the total number of publications written about "L-Selectin" by people in this website by year, and whether "L-Selectin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "L-Selectin" by people in Profiles.
-
Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity. Front Immunol. 2023; 14:1200167.
-
IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy. J Immunol. 2018 10 01; 201(7):2141-2153.
-
Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls. PLoS One. 2017; 12(3):e0174073.
-
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest. 2016 06 01; 126(6):2341-55.
-
Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol. 2012 Sep 15; 303(6):C616-24.
-
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res. 2011 May 15; 71(10):3516-27.
-
Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cell Immunol. 2011; 269(2):135-43.
-
Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem. 2010 Dec 10; 285(50):38751-5.
-
BCR-mediated decrease of CXCR4 and CD62L in CLL. Cancer Res. 2010 Jun 15; 70(12):5194; author reply 5195.
-
Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neurovirol. 2009 Jul; 15(4):334-42.